Publications by authors named "Pierre M Llorca"

Claim this Profile

Mentions over time

Mentions by platform

Video Views

12,705

Total Likes

29

Extended Reach

31,011

Social Features

5
P
Prediction of relapse in a French cohort of outpatients with schizophrenia (FACE-SZ): Prediction, not association.
Susana Barbosa, Ryad Tamouza, Marion Leboyer, Bruno Aouizerate, Christelle Andrieu, Pierre Michel Llorca

Prog Neuropsychopharmacol Biol Psychiatry· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating the efficacy and safety of the currently available once-every-two months long-acting injectable formulations of aripiprazole for the treatment of schizophrenia or as a maintenance monotherapy for bipolar I disorder in adults.
Ludovic Samalin, Ludivine Boudieu, Pierre Michel Llorca

Expert Rev Neurother· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
How can we improve the care of patients with schizophrenia in the real-world? A population-based cohort study of 456,003 patients.
Guillaume Fond, Bruno Falissard, Philippe Nuss, Cedric Collin, Stephanie Duret, Pierre Michel Llorca

Mol Psychiatry· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictors of medication adherence in a large 1-year prospective cohort of individuals with schizophrenia: insights from the multicentric FACE-SZ dataset.
David Misdrahi, Maud Dupuy, Yecodji Dansou, Laurent Boyer, Fabrice Berna, Pierre Michel Llorca

Transl Psychiatry· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Definition of early age at onset in bipolar disorder according to distinctive neurodevelopmental pathways: insights from the FACE-BD study.
Filippo Corponi, Antoine Lefrere, Marion Leboyer, Frank Bellivier, Ophelia Godin, Pierre Michel Llorca

Psychol Med· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world effectiveness of long-acting injectable antipsychotic treatments in a nationwide cohort of 12,373 patients with schizophrenia-spectrum disorders.
Laurent Boyer, Bruno Falissard, Philippe Nuss, Cedric Collin, Stephanie Duret, Pierre Michel Llorca

Mol Psychiatry· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term benzodiazepine prescription in treatment-resistant depression: A national FACE-TRD prospective study.
Guillaume Fond, Mélanie Faugere, Laurent Boyer, Pauline Peri, Florian Stephan, Pierre Michel Llorca

Prog Neuropsychopharmacol Biol Psychiatry· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evolution of Cognitive Impairments in Treatment-Resistant Depression: Results from the Longitudinal French Centers of Expertise for Treatment-Resistant Depression (FACE-DR) Cohort.
Alexis Vancappel, Yecodji Dansou, Ophelia Godin, Emmanuel Haffen, Antoine Yrondi, Pierre Michel Llorca

Brain Sci· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and pharmacological correlates of caffeine consumption in subjects with schizophrenia - Data from the FACE-SZ cohort.
Andrei Szoke, Jean-Romain Richard, Guillaume Fond, David Misdrahi, Mohamed Lajnef, Pierre Michel Llorca

J Psychiatr Res· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association between childhood maltreatment and the clinical course of bipolar disorders: A survival analysis of mood recurrences.
Diane Grillault Laroche, Ophélia Godin, Raoul Belzeaux, Katia M'Bailara, Joséphine Loftus, Pierre Michel Llorca

Acta Psychiatr Scand· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Examining transcranial random noise stimulation as an add-on treatment for persistent symptoms in schizophrenia (STIM'Zo): a study protocol for a multicentre, double-blind, randomized sham-controlled clinical trial.
Jerome Brunelin, Marine Mondino, Julie Haesebaert, Jerome Attal, Michel Benoit, Pierre Michel Llorca

Trials· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influence of Clinical Markers of Dopaminergic Behaviors on Depressive Symptoms During Withdrawal in Cocaine Users.
Julien Cabé, Georges Brousse, Bruno Pereira, Nicolas Cabé, Emily Karsinti, Pierre M Llorca

Front Psychiatry· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Editorial: Dopaminergic Alterations in Schizophrenia.
Mark D Tricklebank, Carol Tamminga, Andrew Grottick, Pierre M Llorca, Silvia Gatti McArthur

Front Neurosci· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Childhood maltreatment and clinical severity of treatment-resistant depression in a French cohort of outpatients (FACE-DR): One-year follow-up.
Antoine Yrondi, Bruno Aouizerate, Djamila Bennabi, Raphaëlle Richieri, Thierry D'Amato, Pierre M Llorca

Depress Anxiety· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reducing Attentional Bias in Individuals With Alcohol Use Disorders With a Tablet Application: A Randomized Controlled Trial Pilot Study.
Valentin Flaudias, Oulmann Zerhouni, Nadia Chakroun-Baggioni, Sylvie Pires, Audrey Schmitt, Pierre Michel Llorca

Alcohol Alcohol· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence of Metabolic Syndrome and Associated Factors in a Cohort of Individuals With Treatment-Resistant Depression: Results From the FACE-DR Study.
Ophélia Godin, Djamila Bennabi, Antoine Yrondi, Raphaelle Richieri, Thierry D'Amato, Pierre Michel Llorca

J Clin Psychiatry· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Compulsive eating behaviors in Parkinson's disease.
Ingrid de Chazeron, Franck Durif, Isabelle Chereau-Boudet, Maria Livia Fantini, Ana Marques, Pierre Michel Llorca

Eat Weight Disord· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Results and validation of an index to measure health state of patients with depression in automated healthcare databases.
François-Xavier Lamy, Bruno Falissard, Clément François, Christophe Lançon, Pierre Michel Llorca

J Mark Access Health Policy· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A tolerability burden index in schizophrenia: incorporating patient perspective in clinical trial adverse event reporting.
Clément François, Alice Guiraud-Diawara, Christophe Lançon, Pierre Michel Llorca, Ann Hartry

J Mark Access Health Policy· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation study of the Medication Adherence Rating Scale. Results from the FACE-SZ national dataset.
Guillaume Fond, Laurent Boyer, Mohamed Boucekine, Latif A Aden, Franck Schürhoff, Pierre Michel Llorca

Schizophr Res· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Determination of Adherence Profiles in Schizophrenia Using Self-Reported Adherence: Results From the FACE-SZ Dataset.
David Misdrahi, Arnaud Tessier, Joel Swendsen, Fabrice Berna, Lore Brunel, Pierre Michel Llorca

J Clin Psychiatry· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis